소개

이 페이지에서는 Gary L Crocker의 공개된 내부자의 매매 거래 내역을 종합적으로 분석합니다. 내부자들은 기업의 임원(내부 경영진), 이사 또는 주요 투자자입니다. 일반적으로 내부자가 중요한 비공개 정보를 기반으로 자신이 속한 기업을 거래하는 것은 불법으로 간주됩니다. 이것은 내부자가 자신의 기업 내에서 행하는 모든 거래가 불법이라는 것을 뜻은 아닙니다. 그러나 그들은 자신들의 모든 거래를 양식 4를 통해 SEC에 보고해야만 합니다. 이러한 제한에도 불구하고, 학계 연구에 따르면 내부자는, 일반적으로, 자신의 회사 주식에 대한 실적이 시장의 수익률을 능가하는 경향성을 보였습니다.

평균 거래 수익성

평균 거래 수익성은 내부자가 지난 3년 동안 매입한 모든 "공개 시장"(Open market)에서의 매입의 평균 수익률입니다. 이를 계산하기 위해 10b5-1 거래 계획의 일부로 표시된 모든 거래를 제외하고 내부자가 계획되지 않은 모든 오픈 마켓에서의 매입을 조사합니다. 그런 다음 3개월, 6개월, 12개월 동안 해당 거래의 평균 성과를 계산하여 각 거래에 대한 최종 성과 지표를 생성합니다. 마지막으로 내부자에 대한 성과 지표를 계산하기 위해 모든 성과 지표의 평균을 내립니다. 이 목록에는 지난 2년 동안 최소 3번 이상 거래한 내부자만 포함됩니다.

내부자의 매매 거래 수익성이 "해당 없음"인 경우, 내부자는 지난 3년 동안 공개 시장에서 매수한 적이 없거나, 거래가 너무 최근에 이루어져서 신뢰할 수 있는 성과 지표를 산출할 수 없는 경우에 해당합니다.

업데이트 주기: 일별

최고 수익율의 내부자 목록을 확인하세요.

내부자 포지션이 보고된 기업

SEC 서류에 따르면 Gary L Crocker 기업이 다음 기업에 대한 보유 또는 거래를 보고했습니다:

증권 소유권 최근 보고된 보유 주식
US:MACK / Merrimack Pharmaceuticals, Inc. See Remarks, Director 133,105
차트 해석 방법

아래 차트는 Gary L Crocker에 의한 각 "공개 시장"(Open market)에서 계획되지 않은 거래 이후 증권의 주가 실적을 보여줍니다. 계획되지 않은 거래는 10b5-1 거래 계획의 일환으로 이루어지지 않은 거래입니다. 주가 실적은 주가의 누적 백분율 변화로 표시됩니다. 예를 들어, 2019년 1월 1일 내부자의 매매 거래가 이루어졌을 경우, 차트는 현재까지 증권의 일별 백분율 변화를 보여줍니다. 이 기간 동안 주가가 10달러에서 15달러로 간다면, 주가의 누적 백분율 변화는 50%가 됩니다. 10달러에서 20달러로의 가격 변화는 100%가 되며, 10달러에서 5달러로의 가격 변화는 -50%가 됩니다.

궁극적으로 내부자의 매매 거래가 내부자의 정보를 이용하여 이익을 얻기 위해 거래 타이밍을 맞추고 있는지 확인하기 위해 내부자의 매매 거래가 주가의 초과 수익률(양 또는 음)과 얼마나 밀접한 상관 관계가 있는지 확인하고자 합니다. 내부자가 이러한 작업을 수행하고 있는 상황을 고려해 보겠습니다. 이러한 상황에서 우리는 (a) 매입 후 양의 수익률 또는 (b) 매각 후 음의 수익률을 기대할 수 있습니다. (a)의 경우, 매입 차트는 상향으로 기울어진 일련의 곡선을 보여주며, 각 매입 거래 후 양의 수익률을 나타냅니다. (b)의 경우, SALE 차트는 하향으로 기울어진 일련의 곡선을 보여주며, 각 판매 거래 후 음의 수익률을 나타냅니다.

그러나 이것만으로는 결론을 도출하기에 충분하지 않습니다. 예를 들어, 해당 기업의 주가가 수년에 걸쳐 비주기적 상승 추세에 있다면, Fintel은 매입 후 도표가 모두 상향 곡선으로 예상할 수 있습니다. 마찬가지로, 수년에 걸쳐 비주기적 하락은 거래 후에 하향 곡선으로 초래할 가능성이 높습니다. 이 도표들 중 어느 것도 내부자의 매매 거래 활동을 시사하지는 않습니다.

가장 강력한 지표는 주가가 극단적으로 순환하는 상황일 것이고, PURCHASE 차트에는 긍정적인 시그널이, SALE 차트에는 부정적인 플롯이 존재했습니다. 이는 자신들의 금전적 이익을 위한 거래 타이밍을 재던 내부자에 의한 상황일 가능성이 높습니다.

내부자의 매매 거래 내역

아래 표는 증권거래위원회(SEC)에 공시된 Gary L Crocker의 내부자의 전체 거래 목록입니다.

보고일 거래일 보고 티커 증권 코드 10b5-1 지분 잔여 지분 변동률
(%)
지분
가치
거래
가치
잔여
가치
2023-08-14 2023-08-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2,000 133,105 1.53 12.43 24,865 1,654,841
2023-08-14 2023-08-10 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2,000 133,105 1.53 12.52 25,039 1,666,421
2022-06-13 2022-06-09 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 4,452 131,105 3.52 5.15 22,918 674,902
2022-06-09 2022-06-08 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 349 126,653 0.28 5.14 1,795 651,452
2022-06-09 2022-06-07 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 300 126,304 0.24 5.05 1,515 637,835
2022-05-26 2022-05-25 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 132 126,004 0.10 5.13 678 647,005
2022-05-26 2022-05-24 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2,323 125,872 1.88 5.09 11,817 640,298
2022-05-23 2022-05-19 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 512 123,549 0.42 5.04 2,582 623,033
2022-05-19 2022-05-18 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 123,037 4.24 5.08 25,407 625,200
2022-05-19 2022-05-17 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 225 118,037 0.19 5.10 1,147 601,469
2022-05-16 2022-05-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3 117,812 0.00 4.90 15 577,279
2022-05-16 2022-05-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2,471 117,809 2.14 5.04 12,456 593,863
2022-04-25 2022-04-21 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 115,338 4.53 6.00 30,001 692,051
2022-04-01 2022-03-31 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 300 110,338 0.27 6.18 1,853 681,525
2022-04-01 2022-03-30 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 161 110,038 0.15 6.20 998 682,236
2022-03-29 2022-03-28 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 109,877 4.77 6.16 30,822 677,315
2022-03-24 2022-03-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 400 104,877 0.38 6.11 2,446 641,197
2022-03-17 2022-03-15 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 4,649 104,477 4.66 6.14 28,556 641,729
2022-03-15 2022-03-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 99,828 5.27 6.02 30,120 601,374
2022-03-15 2022-03-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 94,828 5.57 6.08 30,406 576,678
2022-02-23 2022-02-18 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3,351 89,828 3.88 5.96 19,970 535,312
2022-02-18 2022-02-17 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 86,477 6.14 6.13 30,626 529,689
2022-02-18 2022-02-16 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 7,945 81,477 10.80 6.20 49,231 504,872
2022-02-16 2022-02-15 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 123 73,532 0.17 6.20 763 455,898
2022-02-16 2022-02-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 1,800 73,409 2.51 5.96 10,724 437,341
2022-01-31 2022-01-27 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 673 71,609 0.95 4.60 3,096 329,401
2022-01-27 2022-01-26 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3,100 70,936 4.57 4.56 14,121 323,128
2022-01-25 2022-01-24 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 7,105 67,836 11.70 4.33 30,741 293,506
2022-01-25 2022-01-21 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2,000 60,731 3.41 4.65 9,310 282,691
2022-01-20 2022-01-18 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 58,731 9.31 4.54 22,690 266,515
2022-01-18 2022-01-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 53,731 10.26 4.51 22,554 242,364
2022-01-18 2022-01-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 48,731 11.43 4.42 22,120 215,591
2022-01-13 2022-01-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 43,731 12.91 4.33 21,658 189,425
2022-01-13 2022-01-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 38,731 14.82 4.03 20,140 156,012
2021-06-14 2021-06-10 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 8,000 8,000
2021-04-14 2021-04-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 973 33,731 2.97 6.07 5,905 204,713
2021-04-12 2021-04-09 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 1,200 32,758 3.80 6.10 7,320 199,824
2021-04-09 2021-04-07 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2,127 31,558 7.23 6.19 13,166 195,344
2021-04-01 2021-03-31 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 500 29,431 1.73 6.19 3,094 182,148
2021-03-26 2021-03-25 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 200 28,931 0.70 6.13 1,226 177,347
2021-03-25 2021-03-24 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 28,731 21.07 6.34 31,690 182,097
2021-03-25 2021-03-23 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3,627 23,731 18.04 6.47 23,455 153,461
2021-03-17 2021-03-16 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 20,104 33.10 6.79 33,956 136,530
2021-03-05 2021-02-23 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 15,104 49.49 7.20 36,004 108,762
2021-02-17 2021-02-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 10,104 97.96 7.47 37,342 75,461
2021-02-12 2021-02-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 1,604 5,104 45.83 7.98 12,798 40,722
2021-02-12 2021-02-10 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3,500 3,500 7.64 26,757 26,757
2020-08-03 2020-07-30 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 8,000 8,000
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -6,228 0 -100.00 3.20 -19,942
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -17,250 0 -100.00 3.20 -55,234
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -52,068 0 -100.00 3.04 -158,386
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -86,549 0 -100.00 3.04 -263,273
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -8,428 0 -100.00 3.20 -26,986
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -5,986 0 -100.00 3.04 -18,209
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -17,000 0 -100.00 3.20 -54,434
2019-10-21 2019-10-17 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 8,000 8,000
2018-06-15 2018-06-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 8,000 8,000
2017-09-15 2017-09-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 8,625 8,625
2016-06-16 2016-06-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 49,500 49,500
2015-05-18 2015-05-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 17,500 17,500
2015-04-10 2015-04-02 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -50,000 0 -100.00
2015-04-10 2015-04-02 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -35,000 0 -100.00
2015-04-10 2015-04-02 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 50,000 2,943,961 1.73 2.47 123,500 7,271,584
2015-04-10 2015-04-02 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 35,000 2,893,961 1.22 1.71 59,850 4,948,673
2014-11-14 2014-11-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 8,630 2,858,961 0.30 8.37 72,233 23,929,504
2014-11-14 2014-11-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,760 2,850,331 0.20 8.62 49,651 24,569,853
2014-06-24 2014-06-23 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 36,000 2,844,571 1.28 6.84 246,240 19,456,866
2014-05-22 2014-05-20 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 4,000 2,808,571 0.14 6.69 26,760 18,789,340
2014-05-20 2014-05-19 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 6,000 2,804,571 0.21 6.71 40,260 18,818,671
2014-05-20 2014-05-16 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3,400 2,798,571 0.12 6.63 22,542 18,554,526
2014-05-15 2014-05-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 37,834 37,834
2014-05-08 2014-05-07 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 4,400 2,795,171 0.16 6.77 29,788 18,923,308
2014-05-07 2014-05-06 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 7,500 2,790,771 0.27 6.85 51,375 19,116,781
2014-05-07 2014-05-05 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 10,000 2,783,271 0.36 6.92 69,200 19,260,235
2014-05-06 2014-05-05 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -35,000 0 -100.00
2014-05-06 2014-05-05 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 35,000 2,773,271 1.28 1.25 43,750 3,466,589
2014-05-06 2014-05-05 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 10,000 2,738,271 0.37 6.69 66,900 18,319,033
2014-03-14 2014-03-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -50,000 0 -100.00
2014-03-14 2014-03-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 50,000 2,728,271 1.87 1.25 62,500 3,410,339
2013-12-02 2013-11-27 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 69,000 2,678,271 2.64 3.74 257,998 10,014,323
2013-12-02 2013-11-27 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 69,000 2,609,271 2.72 3.71 255,755 9,671,524
2013-12-02 2013-11-27 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 69,000 2,540,271 2.79 3.71 255,783 9,416,785
2013-06-13 2013-06-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 37,834 37,834
2013-02-13 2012-12-19 5 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
G - Gift 15,015 2,471,271 0.61
2013-02-13 2012-12-19 5 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
G - Gift 15,015 2,456,256 0.62
2013-02-13 2012-12-19 5 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
G - Gift -90,090 2,441,241 -3.56
2013-02-13 2012-12-19 5 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
G - Gift 39,000 2,531,331 1.56
2013-02-13 2012-12-19 5 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
G - Gift -39,000 2,492,331 -1.54
2012-12-17 2012-12-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 36,500 2,531,331 1.46 6.77 247,214 17,144,705
2012-09-18 2012-09-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 25,800 2,494,831 1.04 8.34 215,172 20,806,891
2012-09-18 2012-09-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 39,000 2,469,031 1.60 8.32 324,437 20,539,622
2012-08-27 2012-08-23 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 31,600 31,600
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series F Convertible Preferred Stock
C - Conversion -450,000 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series G Convertible Preferred Stock
C - Conversion -22,000 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series G Convertible Preferred Stock
C - Conversion -22,000 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series F Convertible Preferred Stock
C - Conversion -23,300 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series F Convertible Preferred Stock
C - Conversion -23,300 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series E Convertible Preferred Stock
C - Conversion -28,332 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series E Convertible Preferred Stock
C - Conversion -28,332 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -21,429 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -21,429 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -79,000 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -79,000 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -35,714 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -184,975 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series E Convertible Preferred Stock
C - Conversion -300,000 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -30,000 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -15,863 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series G Convertible Preferred Stock
C - Conversion -313,266 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series F Convertible Preferred Stock
C - Conversion -41,900 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series E Convertible Preferred Stock
C - Conversion -46,676 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -463,654 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -59,863 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 450,000 2,430,031 22.73
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 22,000 1,980,031 1.12
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 22,000 1,980,031 1.12
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 23,300 1,958,031 1.20
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 23,300 1,958,031 1.20
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 28,332 1,934,731 1.49
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 28,332 1,934,731 1.49
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 21,429 1,906,399 1.14
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 21,429 1,906,399 1.14
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 79,000 1,884,970 4.37
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 79,000 1,884,970 4.37
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 35,714 1,631,909 2.24
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 184,975 1,596,195 13.11
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 300,000 1,411,220 27.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 30,000 1,111,220 2.77
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 15,863 1,081,220 1.49
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 313,266 1,065,357 41.65
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 41,900 752,091 5.90
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 46,676 710,191 7.03
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 463,654 663,515 231.99
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 59,863 199,861 42.76
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 25,000 139,998 21.74 7.00 175,000 979,986
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 21,428 114,998 22.90 7.00 149,996 804,986
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 14,285 93,570 18.02 7.00 99,995 654,990
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 15,000 79,285 23.33 7.00 105,000 554,995
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 64,285 64,285 7.00 449,995 449,995
P
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입
S
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각
A
자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득
C
파생상품 전환
D
자사에게 유가증권을 매각 또는 양도
F
기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급
G
내부자에 의한 또는 내부자에게 증권 증여
K
지분스왑 및 유사 위험 회피거래
M
자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환
V
보고서 양식 4에 자진 신고된 거래
J
기타 (거래 내용을 설명하는 각주와 동반)